SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 318.77 |
| Enterprise Value ($M) | -115.31 |
| Book Value ($M) | 408.96 |
| Book Value / Share | 5.98 |
| Price / Book | 0.78 |
| NCAV ($M) | 392.07 |
| NCAV / Share | 5.74 |
| Price / NCAV | 0.81 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.32 |
| Return on Assets (ROA) | -0.49 |
| Return on Equity (ROE) | -0.55 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 10.40 |
| Current Ratio | 10.40 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 434.09 |
| Assets | 450.98 |
| Liabilities | 42.02 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -142.26 |
| Net Income | -129.47 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -104.35 |
| Cash from Investing | -93.53 |
| Cash from Financing | 268.82 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Paradigm Biocapital Advisors LP | 9.99 | 34.99 | |
| 13G/A | Bain Capital Life Sciences Opportunities IV, L.P. | 9.99 | -5.01 | |
| 13D/A | Biotechnology Value Fund L P | 9.99 | -17.28 | |
| 13G/A | Deep Track Capital, LP | 6.98 | 31.57 | |
| 13G | Point72 Asset Management, L.P. | 5.70 | ||
| 13D/A | Logos Global Management LP | 5.80 | -23.86 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 70,179 | 417,443 | 16.81 | |
| 139,808 | 525,125 | 26.62 | |
| 524,916 | 1,567,462 | 33.49 | |
| 391,842 | 1,615,700 | 24.25 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| NVAX – Novavax, Inc. | NXTC – NextCure, Inc. |
| OGI – Organigram Global Inc. | OPK – OPKO Health, Inc. |
| OPTN – OptiNose, Inc. |
Financial data and stock pages provided by
Fintel.io